secwatch.observer — SEC 8-K summary
======================================

Issuer:     Protagenic Therapeutics, Inc.new (PTIX)
CIK:        0001022899
Form:       8-K
Filed at:   2025-10-31T23:59:59+00:00
Accession:  0001493152-25-020444
Event type: litigation
Sentiment:  negative
Materiality: 0.75
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Protagenic Therapeutics files suit to rescind Phytanix Bio acquisition or seek damages
--------------------------------------------------------------------------------

- Filed Verified Complaint in Delaware Chancery Court on October 28, 2025.
- Seeks rescission of May 15, 2025 Share Exchange Agreement acquiring Phytanix Bio.
- Alternatively seeks damages and an order compelling delivery of audited financials.
- Lawsuit challenges the entire transaction; no settlement or resolution disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1022899/000149315225020444/0001493152-25-020444-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1022899/000149315225020444/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-020444

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer